{"transactions":[{"id":758378,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-29T23:08:44.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":0.7989,"exercise_date":"2027-05-28","expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-26-249113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696493/000119312526249113/ownership.xml","form_type":"4"}},{"id":937076,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-16T22:00:04.000Z","date":"2026-01-10","kind":"exercise","planned":false,"acquired":false,"shares":3430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3430},"source":{"system":"sec-edgar","filing":"0001193125-26-015485","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000119312526015485/ownership.xml","form_type":"4"}},{"id":937075,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-16T22:00:04.000Z","date":"2026-01-10","kind":"exercise","planned":false,"acquired":true,"shares":3430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."}],"balance_after":3430,"source":{"system":"sec-edgar","filing":"0001193125-26-015485","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000119312526015485/ownership.xml","form_type":"4"}},{"id":1128871,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-05-30T22:50:27.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":107400,"derivative":{"exercise_price":0.4444,"exercise_date":"2026-05-29","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0000950170-25-079943","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696493/000095017025079943/ownership.xml","form_type":"4"}},{"id":1304236,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-13T22:30:05.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":3430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the total restricted stock units will vest on January 10, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the total restricted stock units will vest on January 10, 2026."}],"balance_after":3430,"derivative":{"underlying":"Common Stock","underlying_shares":3430},"source":{"system":"sec-edgar","filing":"0000950170-25-004915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025004915/ownership.xml","form_type":"4"}},{"id":1304235,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-13T22:30:05.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":30870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase up to 30,870 shares of common stock, which option vests with respect to 100% of the total number of shares on January 10, 2026."}],"balance_after":30870,"derivative":{"exercise_price":4.04,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":30870},"source":{"system":"sec-edgar","filing":"0000950170-25-004915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025004915/ownership.xml","form_type":"4"}},{"id":1383386,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-10-22T00:38:52.000Z","date":"2024-10-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 31, 2025, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":34000,"derivative":{"exercise_price":2.04,"exercise_date":"2025-05-31","expiration_date":"2034-10-17","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0000950170-24-116060","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696493/000095017024116060/ownership.xml","form_type":"4"}},{"id":1858233,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-06-13T00:17:24.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":29532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant  or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":29532,"derivative":{"exercise_price":7.12,"exercise_date":"2024-06-09","expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":29532},"source":{"system":"sec-edgar","filing":"0001209191-23-036510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696493/000120919123036510/doc4.xml","form_type":"4"}},{"id":1908123,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-02T22:43:30.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":150437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase up to 150,437 shares of Common Stock, which option vests with respect to 75,219 shares on May 1, 2024 and with respect to 75,218 shares on May 1, 2025."}],"balance_after":150437,"derivative":{"exercise_price":2.3,"expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":150437},"source":{"system":"sec-edgar","filing":"0001209191-23-026724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000120919123026724/doc4.xml","form_type":"4"}},{"id":1992258,"issuer":{"id":116342,"kind":"organization","name":"CinCor Pharma, Inc.","symbol":"CINC"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-24T23:37:25.000Z","date":"2023-02-24","kind":"disposition_to_issuer","acquired":false,"shares":47954,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 8, 2023, by and among CinCor Pharma, Inc. (the \"Issuer\"), AstraZeneca Finance and Holdings Inc. (\"Parent\") and Cinnamon Acquisition, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), on February 24, 2023, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option with an exercise price less than $26.00 per share (the \"Cash Amount\") was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive, without interest, (i) cash in an amount equal to the product of (1) the total number of Shares subject to such option as of immediately prior to the effective time of the merger multiplied by (2) the excess of the Cash Amount over the exercise price payable per Share under such option, and (ii) one contingent value right per Share subject to such option, representing the right to receive a contingent payment of $10.00 per share, in cash, upon the achievement of a specified milestone by December 31, 2033."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option with an exercise price less than $26.00 per share (the \"Cash Amount\") was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive, without interest, (i) cash in an amount equal to the product of (1) the total number of Shares subject to such option as of immediately prior to the effective time of the merger multiplied by (2) the excess of the Cash Amount over the exercise price payable per Share under such option, and (ii) one contingent value right per Share subject to such option, representing the right to receive a contingent payment of $10.00 per share, in cash, upon the achievement of a specified milestone by December 31, 2033."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2032-01-10","underlying":"Common Stock","underlying_shares":47954},"source":{"system":"sec-edgar","filing":"0001209191-23-012893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696493/000120919123012893/doc4.xml","form_type":"4"}},{"id":2035745,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T23:05:38.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase up to 20,000 shares of Common Stock, which option vests with respect to 100% of the total number of shares on 2/1/2024."}],"balance_after":20000,"derivative":{"exercise_price":3.08,"expiration_date":"2033-02-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-006345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000120919123006345/doc4.xml","form_type":"4"}},{"id":2233623,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-06-14T00:56:32.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":39727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant  or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":39727,"derivative":{"exercise_price":5.26,"exercise_date":"2023-06-10","expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":39727},"source":{"system":"sec-edgar","filing":"0001209191-22-036531","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696493/000120919122036531/doc4.xml","form_type":"4"}},{"id":2416281,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T22:32:07.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase up to 20,000 shares of Common Stock, which option vests with respect to 100% of the total number of shares on 2/1/2023."}],"balance_after":20000,"derivative":{"exercise_price":3.97,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-006471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000120919122006471/doc4.xml","form_type":"4"}},{"id":2438638,"issuer":{"id":116342,"kind":"organization","name":"CinCor Pharma, Inc.","symbol":"CINC"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-10T21:15:26.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":47954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in equal annual installments over a three-year period measured from one year following January 11, 2022, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date."}],"balance_after":47954,"derivative":{"exercise_price":16,"expiration_date":"2032-01-10","underlying":"Common Stock","underlying_shares":47954},"source":{"system":"sec-edgar","filing":"0001209191-22-002684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696493/000120919122002684/doc4.xml","form_type":"4"}},{"id":2500014,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-23T00:41:11.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":18937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option granted on November 19, 2021 became vested and exercisable as of December 19, 2021 and 1/36th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date."}],"balance_after":18937,"derivative":{"exercise_price":21.65,"exercise_date":"2021-12-19","expiration_date":"2031-11-29","underlying":"Common Stock","underlying_shares":18937},"source":{"system":"sec-edgar","filing":"0001209191-21-066224","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696493/000120919121066224/doc4.xml","form_type":"4"}},{"id":3386130,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2019-02-25","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On February 1, 2017, the Reporting Person was granted an option to purchase 25,000 shares of Common Stock under the issuer's 2015 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On June 28, 2018, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 6,250 of the shares underlying such option."}],"balance_after":3250,"derivative":{"exercise_price":11.95,"exercise_date":"2018-06-28","expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386129,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2018-12-03","kind":"exercise","acquired":false,"shares":364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":100613,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":364},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386128,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2018-11-06","kind":"exercise","acquired":false,"shares":364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":100977,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":364},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386127,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2018-10-11","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":101341,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386126,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":103841,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":364},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386125,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2018-09-04","kind":"exercise","acquired":false,"shares":364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":104205,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":364},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386124,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2018-08-09","kind":"exercise","acquired":false,"shares":363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":104569,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":363},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386123,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2018-07-10","kind":"exercise","acquired":false,"shares":364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":104932,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":364},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386122,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2018-05-31","kind":"exercise","acquired":false,"shares":364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":105296,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":364},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386121,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2018-05-09","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":105660,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386120,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-29T20:31:45.000Z","date":"2018-05-02","kind":"exercise","acquired":false,"shares":5457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":110160,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":5457},"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386119,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2019-02-25","kind":"exercise","acquired":true,"shares":3000,"price":11.95,"value":35850.0,"ownership":{"direct":true},"balance_after":22157,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386118,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2018-12-03","kind":"exercise","acquired":true,"shares":364,"price":11.95,"value":4349.8,"ownership":{"direct":true},"balance_after":19157,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386117,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2018-11-06","kind":"exercise","acquired":true,"shares":364,"price":11.95,"value":4349.8,"ownership":{"direct":true},"balance_after":18793,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386116,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2018-10-11","kind":"exercise","acquired":true,"shares":2500,"price":11.95,"value":29875.0,"ownership":{"direct":true},"balance_after":18429,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386115,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":364,"price":11.95,"value":4349.8,"ownership":{"direct":true},"balance_after":15929,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386114,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":364,"price":11.95,"value":4349.8,"ownership":{"direct":true},"balance_after":15565,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386113,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2018-08-09","kind":"exercise","acquired":true,"shares":363,"price":11.95,"value":4337.85,"ownership":{"direct":true},"balance_after":15201,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386112,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2018-07-10","kind":"exercise","acquired":true,"shares":364,"price":11.95,"value":4349.8,"ownership":{"direct":true},"balance_after":14838,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386111,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2018-05-31","kind":"exercise","acquired":true,"shares":364,"price":11.95,"value":4349.8,"ownership":{"direct":true},"balance_after":14474,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386110,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2018-05-09","kind":"exercise","acquired":true,"shares":4500,"price":11.95,"value":53775.0,"ownership":{"direct":true},"balance_after":14110,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3386109,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:31:45.000Z","date":"2018-05-02","kind":"exercise","acquired":true,"shares":5457,"price":11.95,"value":65211.15,"ownership":{"direct":true},"balance_after":9610,"source":{"system":"sec-edgar","filing":"0000899243-19-026147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319026147/doc4.xml","form_type":"4"}},{"id":3406808,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-24T18:23:32.000Z","date":"2019-09-23","kind":"exercise","acquired":false,"shares":12625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":115617,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":12625},"source":{"system":"sec-edgar","filing":"0000899243-19-024190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024190/doc4.xml","form_type":"4"}},{"id":3406807,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-09-24T18:23:32.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":4161,"price":61.089,"value":254191.329,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $60.69 to $61.65 per share."}],"balance_after":4153,"source":{"system":"sec-edgar","filing":"0000899243-19-024190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024190/doc4.xml","form_type":"4"}},{"id":3406806,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-09-24T18:23:32.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":800,"price":59.95,"value":47960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $59.69 to $60.64 per share."}],"balance_after":8314,"source":{"system":"sec-edgar","filing":"0000899243-19-024190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024190/doc4.xml","form_type":"4"}},{"id":3406805,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-09-24T18:23:32.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":4161,"price":58.9736,"value":245389.1496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $58.69 to $59.65 per share."}],"balance_after":9114,"source":{"system":"sec-edgar","filing":"0000899243-19-024190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024190/doc4.xml","form_type":"4"}},{"id":3406804,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-09-24T18:23:32.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":3929,"price":58.3313,"value":229183.6777,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $57.69 to $58.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4."}],"balance_after":13275,"source":{"system":"sec-edgar","filing":"0000899243-19-024190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024190/doc4.xml","form_type":"4"}},{"id":3406803,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-09-24T18:23:32.000Z","date":"2019-09-23","kind":"exercise","acquired":true,"shares":12625,"price":11.95,"value":150868.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."}],"balance_after":17204,"source":{"system":"sec-edgar","filing":"0000899243-19-024190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024190/doc4.xml","form_type":"4"}},{"id":3408752,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-20T17:31:40.000Z","date":"2019-09-19","kind":"exercise","acquired":false,"shares":5435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":128242,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":5435},"source":{"system":"sec-edgar","filing":"0000899243-19-024005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024005/doc4.xml","form_type":"4"}},{"id":3408751,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-09-20T17:31:40.000Z","date":"2019-09-19","kind":"sale","acquired":false,"shares":5435,"price":57.0844,"value":310253.714,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $57.00 to $57.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4579,"source":{"system":"sec-edgar","filing":"0000899243-19-024005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024005/doc4.xml","form_type":"4"}},{"id":3408750,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-09-20T17:31:40.000Z","date":"2019-09-19","kind":"exercise","acquired":true,"shares":5435,"price":11.95,"value":64948.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."}],"balance_after":10014,"source":{"system":"sec-edgar","filing":"0000899243-19-024005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319024005/doc4.xml","form_type":"4"}},{"id":3440785,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-12T20:40:43.000Z","date":"2019-08-09","kind":"exercise","acquired":false,"shares":4565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":133677,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":4565},"source":{"system":"sec-edgar","filing":"0000899243-19-021602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319021602/doc4.xml","form_type":"4"}},{"id":3440784,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-08-12T20:40:43.000Z","date":"2019-08-09","kind":"sale","acquired":false,"shares":4565,"price":57.003,"value":260218.695,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $57.00 to $57.04 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":4579,"source":{"system":"sec-edgar","filing":"0000899243-19-021602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319021602/doc4.xml","form_type":"4"}},{"id":3440783,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-08-12T20:40:43.000Z","date":"2019-08-09","kind":"exercise","acquired":true,"shares":4565,"price":11.95,"value":54551.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person."}],"balance_after":9144,"source":{"system":"sec-edgar","filing":"0000899243-19-021602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319021602/doc4.xml","form_type":"4"}},{"id":3504280,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-06-03T17:48:58.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":401,"price":40.783,"value":16353.983,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2013 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)."}],"balance_after":4579,"source":{"system":"sec-edgar","filing":"0000899243-19-015397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319015397/doc4.xml","form_type":"4"}},{"id":3590024,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-18T17:32:17.000Z","date":"2019-03-14","kind":"exercise","acquired":false,"shares":1758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":138242,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":1758},"source":{"system":"sec-edgar","filing":"0000899243-19-008163","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319008163/doc4.xml","form_type":"4"}},{"id":3590023,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-18T17:32:17.000Z","date":"2019-03-14","kind":"exercise","acquired":true,"shares":1758,"price":11.95,"value":21008.1,"ownership":{"direct":true},"balance_after":4178,"source":{"system":"sec-edgar","filing":"0000899243-19-008163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319008163/doc4.xml","form_type":"4"}},{"id":3662460,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-02-12T16:28:13.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":22600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2019, so that all of the underlying shares shall be vested on January 1, 2023, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":22600,"derivative":{"underlying":"Common Stock","underlying_shares":22600},"source":{"system":"sec-edgar","filing":"0000899243-19-003295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319003295/doc4.xml","form_type":"4"}},{"id":3662459,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-12T16:28:13.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly installments from January 1, 2019, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":65000,"derivative":{"exercise_price":40.11,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000899243-19-003295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319003295/doc4.xml","form_type":"4"}},{"id":3698799,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-01-09T21:36:47.000Z","date":"2019-01-07","kind":"tax_withholding","acquired":false,"shares":1100,"price":44.0613,"value":48467.43,"ownership":{"direct":true},"balance_after":2420,"source":{"system":"sec-edgar","filing":"0000899243-19-000913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319000913/doc4.xml","form_type":"4"}},{"id":3707484,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-01-03T21:41:07.000Z","date":"2019-01-01","kind":"exercise","acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":8250,"derivative":{"underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0000899243-19-000380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319000380/doc4.xml","form_type":"4"}},{"id":3707483,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-01-03T21:41:07.000Z","date":"2019-01-01","kind":"exercise","acquired":true,"shares":2750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":3520,"source":{"system":"sec-edgar","filing":"0000899243-19-000380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924319000380/doc4.xml","form_type":"4"}},{"id":3740744,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-06T20:13:51.000Z","date":"2018-12-03","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-18-030319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318030319/doc4.xml","form_type":"4"}},{"id":3740743,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-06T20:13:51.000Z","date":"2018-12-03","kind":"sale","acquired":true,"shares":200,"price":63.76,"value":12752.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":770,"source":{"system":"sec-edgar","filing":"0000899243-18-030319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318030319/doc4.xml","form_type":"4"}},{"id":3740742,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-06T20:13:51.000Z","date":"2018-12-03","kind":"sale","acquired":true,"shares":800,"price":62.2586,"value":49806.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $62.11 to $62.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":970,"source":{"system":"sec-edgar","filing":"0000899243-18-030319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318030319/doc4.xml","form_type":"4"}},{"id":3740741,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-06T20:13:51.000Z","date":"2018-12-03","kind":"sale","acquired":true,"shares":1200,"price":61.0711,"value":73285.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $60.89 to $61.32 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1770,"source":{"system":"sec-edgar","filing":"0000899243-18-030319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318030319/doc4.xml","form_type":"4"}},{"id":3740740,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-06T20:13:51.000Z","date":"2018-12-03","kind":"sale","acquired":true,"shares":2800,"price":60.077,"value":168215.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $59.58 to $60.54 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2970,"source":{"system":"sec-edgar","filing":"0000899243-18-030319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318030319/doc4.xml","form_type":"4"}},{"id":3740739,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-06T20:13:51.000Z","date":"2018-12-03","kind":"exercise","acquired":true,"shares":5000,"price":11.95,"value":59750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":5770,"source":{"system":"sec-edgar","filing":"0000899243-18-030319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318030319/doc4.xml","form_type":"4"}},{"id":3740738,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-06T20:13:51.000Z","date":"2018-10-31","kind":"grant","acquired":true,"shares":344,"price":42.16,"value":14503.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":770,"source":{"system":"sec-edgar","filing":"0000899243-18-030319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318030319/doc4.xml","form_type":"4"}},{"id":3808844,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-24T20:26:31.000Z","date":"2018-09-21","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested and became exercisable on January 31, 2018, and the remaining shares subject to this option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":145000,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-18-025124","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318025124/doc4.xml","form_type":"4"}},{"id":3808843,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-09-24T20:26:31.000Z","date":"2018-09-21","kind":"sale","acquired":false,"shares":908,"price":63.8359,"value":57962.9972,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $63.45 to $64.35 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":426,"source":{"system":"sec-edgar","filing":"0000899243-18-025124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318025124/doc4.xml","form_type":"4"}},{"id":3808842,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-09-24T20:26:31.000Z","date":"2018-09-21","kind":"sale","acquired":false,"shares":4092,"price":62.9739,"value":257689.1988,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $62.40 to $63.30 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1334,"source":{"system":"sec-edgar","filing":"0000899243-18-025124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318025124/doc4.xml","form_type":"4"}},{"id":3808841,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-09-24T20:26:31.000Z","date":"2018-09-21","kind":"exercise","acquired":true,"shares":5000,"price":11.95,"value":59750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":5426,"source":{"system":"sec-edgar","filing":"0000899243-18-025124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318025124/doc4.xml","form_type":"4"}},{"id":3880266,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-29T17:45:06.000Z","date":"2018-06-28","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On February 1, 2017, the Reporting Person was granted an option to purchase 25,000 shares of Common Stock under the issuer's 2015 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On June 28, 2018, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 6,250 of the shares underlying such option."}],"balance_after":6250,"derivative":{"exercise_price":11.95,"exercise_date":"2018-06-28","expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000899243-18-018746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318018746/doc4.xml","form_type":"4"}},{"id":3910301,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-01T16:25:59.000Z","date":"2018-04-30","kind":"grant","acquired":true,"shares":426,"price":33.15,"value":14121.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":426,"source":{"system":"sec-edgar","filing":"0000899243-18-014679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318014679/doc4.xml","form_type":"4"}},{"id":4095702,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-01-18T19:59:22.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in equal annual installments over 4 years from January 1, 2018, so that all of the underlying shares shall be vested on January 1, 2022, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer."}],"balance_after":11000,"derivative":{"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000899243-18-001389","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318001389/doc4.xml","form_type":"4"}},{"id":4095701,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T19:59:22.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":66400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option vest in 48 equal monthly  installments from January 1, 2018, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer."}],"balance_after":66400,"derivative":{"exercise_price":52,"expiration_date":"2028-01-15","underlying":"Common Stock","underlying_shares":66400},"source":{"system":"sec-edgar","filing":"0000899243-18-001389","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924318001389/doc4.xml","form_type":"4"}},{"id":4473103,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-01T18:53:33.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on January 31, 2018, and the remaining shares subject to this option shall vest and become exercisable in 36 equal monthly installments thereafter.  This option is subject to full acceleration of vesting with respect to all then-unvested shares in the event the reporting person's service relationship is terminated by the issuer or any successor without Cause (as defined in the issuer's 2015 Stock Option and Incentive Plan) within one year following the  consummation of a Sale Event (as defined in the issuer's 2015 Stock Option and Incentive Plan)."}],"balance_after":150000,"derivative":{"exercise_price":11.95,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-17-002398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552451/000089924317002398/doc4.xml","form_type":"4"}}]}